BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.
Share
Read more
Share
BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.
Read more